About
Equashield International is a global leader in compounding technology, focusing on closed system transfer devices (CSTDs) and automated compounding solutions. Founded in 2009, the company prioritizes product innovation and safety, serving customers across five continents, particularly in the US market. Their product portfolio features proprietary manual CSTDs and advanced automated compounding systems that utilize artificial intelligence to enhance performance and safety. These technologies aim to improve the handling of hazardous drugs in healthcare settings, minimizing contamination risks for professionals and facilities. Equashield also offers educational resources through its EQ Academy, providing blogs, tutorials, videos, and podcasts on safe drug handling practices. The company primarily serves healthcare providers, pharmacies, and institutions involved in drug compounding and administration. Headquartered in Tefen, Israel, with significant operations in New York, Equashield employs around 460 people and reported revenues of approximately EUR 120 million in 2024.
Keywords
Company Information
-
Employees 1
-
Founded 2009
Location
Technologiepark-Zwijnaarde, Ghent, Flanders, Belgium, 9052
